Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| 1 |
Boston Scientific
BSX
|
+$1.3B |
| 2 |
Progressive
PGR
|
+$794M |
| 3 |
Morgan Stanley
MS
|
+$701M |
| 4 |
Icon
ICLR
|
+$474M |
| 5 |
Fiserv
FI
|
+$462M |
Top Sells
| 1 |
Zimmer Biomet
ZBH
|
+$912M |
| 2 |
State Street
STT
|
+$775M |
| 3 |
Accenture
ACN
|
+$578M |
| 4 |
Alibaba
BABA
|
+$562M |
| 5 |
Goldman Sachs
GS
|
+$480M |
Sector Composition
| 1 | Technology | 21.43% |
| 2 | Financials | 18.37% |
| 3 | Healthcare | 14.91% |
| 4 | Industrials | 13.45% |
| 5 | Communication Services | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Sana Biotechnology
SANA
$739M
| $16.3M | 0.01% |
+487,166
| New | +$16.3M |
|
627
Health Catalyst
HCAT
$229M
| $16.3M | 0.01% |
348,482
-153,246
| -31% | -$7.17M |
|
628
Cactus
WHD
$2.84B
| $16.1M | 0.01% |
526,642
+44,805
| +9% | +$1.37M |
|
629
NiSource
NI
$19.2B
| $15.9M | ﹤0.01% |
660,703
-2,539,432
| -79% | -$61.2M |
|
630
Cheniere Energy
LNG
$52.1B
| $15.9M | ﹤0.01% |
220,536
-833,148
| -79% | -$60M |
|
631
Oneok
OKE
$46.2B
| $15.6M | ﹤0.01% |
308,346
-22,992
| -7% | -$1.16M |
|
632
Altria Group
MO
$111B
| $15.3M | ﹤0.01% |
299,491
-119,802
| -29% | -$6.13M |
|
633
Collegium Pharmaceutical
COLL
$1.19B
| $15.2M | ﹤0.01% |
643,322
-16,417
| -2% | -$389K |
|
634
Cummins
CMI
$55.8B
| $15M | ﹤0.01% |
58,008
-2,125
| -4% | -$551K |
|
|
MOR
635
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $14.6M | ﹤0.01% |
671,606
-15,492
| -2% | -$338K |
|
|
KLRS
636
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.1M
| $14.4M | ﹤0.01% |
26,668
-626
| -2% | -$337K |
|
|
SILK
637
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $14.2M | ﹤0.01% |
279,508
-50,927
| -15% | -$2.58M |
|
638
Neurocrine Biosciences
NBIX
$14B
| $14M | ﹤0.01% |
143,747
-3,373
| -2% | -$328K |
|
639
Huntington Ingalls Industries
HII
$10.7B
| $13.5M | ﹤0.01% |
65,714
-16,079
| -20% | -$3.31M |
|
640
Evercore
EVR
$12.8B
| $13.3M | ﹤0.01% |
100,805
+41,129
| +69% | +$5.42M |
|
|
OCFT
641
OneConnect Financial Technology
OCFT
$281M
| $13.2M | ﹤0.01% |
89,233
+45,109
| +102% | +$6.67M |
|
|
B
642
Barrick Mining Corporation
B
$50.3B
| $13.1M | ﹤0.01% |
659,449
-2,143,626
| -76% | -$42.4M |
|
643
Avantor
AVTR
$8.6B
| $12.9M | ﹤0.01% |
446,446
+329,308
| +281% | +$9.53M |
|
644
Eagle Materials
EXP
$7.49B
| $12.7M | ﹤0.01% |
94,434
-6,247
| -6% | -$840K |
|
645
SAP
SAP
$303B
| $12.5M | ﹤0.01% |
101,514
+8,697
| +9% | +$1.07M |
|
|
DTP
646
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
| $12.5M | ﹤0.01% |
250,700
| – | – |
|
647
BioXcel Therapeutics
BTAI
$51.2M
| $12.5M | ﹤0.01% |
18,038
-435
| -2% | -$300K |
|
648
Amicus Therapeutics
FOLD
$2.45B
| $12.5M | ﹤0.01% |
1,260,156
+80,472
| +7% | +$795K |
|
|
NEE.PRP
649
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
| $12.4M | ﹤0.01% |
250,700
| – | – |
|
650
JD.com
JD
$47.2B
| $12.3M | ﹤0.01% |
145,740
-63,804
| -30% | -$5.38M |
|